7x Winner of the MMIT Patient Choice Award!

Give us a call 855.726.8479 | 412.246.9858

RYSTIGGO® (rozanolixizumab-noli)
www.rystiggo.com

RYSTIGGO (rozanolixizumab-noli) is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.